Silver Falcon PLC Result of General Meeting (6971S)
04 October 2017 - 9:16PM
UK Regulatory
TIDMSILF
RNS Number : 6971S
Silver Falcon PLC
04 October 2017
Silver Falcon Plc
("SILF" or "the Company")
Result of General Meeting
Silver Falcon Plc, (LSE: SILF), which has agreed to acquire the
biotechnology company Hemogenyx Pharmaceuticals Limited
("Hemogenyx"), announces that following a General Meeting of the
Company today all resolutions were duly approved by shareholders,
including in relation to the waiver of Rule 9 of the Takeover Code
and the Placing and Subscription.
Accordingly, the Acquisition and the related Placing and
Subscription will complete tomorrow, 5 October 2017, subject only
to the readmission of the enlarged share capital to the standard
listing segment of the Official List and to trading on the main
market for listed securities of the London Stock Exchange
("Admission"), which is expected to commence at 8.00 a.m. on 5
October 2017.
On Admission, the Company's total issued share capital will
consist of 356,042,854 Ordinary Shares of GBP0.01 each. The Company
holds no Ordinary Shares in treasury. The above figure
(356,042,854) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by
which they will determine if they are required to notify their
interest in, or a change to their interest in, Hemogenyx
Pharmaceuticals plc under the FCA's Disclosure Guidance and
Transparency Rules.
The Company will trade under the new company name of Hemogenyx
Pharmaceuticals Plc and the Company's new London Stock Exchange
TIDM ticker symbol will be HEMO and its ISIN will remain as
GB00BYX3WZ24.
In addition, the Company's new website address will be
www.hemogenyx.com
Enquiries:
Hemogenyx Pharmaceuticals Limited www.hemogenyx.com
Peter Redmond, Director Via Walbrook PR
Optiva Securities Ltd Tel: +44 (0)20 3137
1902
Christian Dennis
Shard Capital Partners LLP Tel: +44 (0)20 7186
9950
Damon Heath, Erik Woolgar
Peterhouse Corporate Finance Tel: +44 (0)20 7469
Limited 0930
Lucy Williams/Duncan Vasey
Walbrook PR Tel: +44 (0)20 7933 8780 or
hemogenyx@walbrookpr.com
Paul McManus Mob: +44 (0)7980 541 893
Flowcomms IR Mob: +44 (0)7891 627 441 or
sasha@flowcomms.com
Sasha Sethi
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMOKQDDKBDDPKK
(END) Dow Jones Newswires
October 04, 2017 06:16 ET (10:16 GMT)
Silver Falcon (LSE:SILF)
Historical Stock Chart
From Apr 2024 to May 2024
Silver Falcon (LSE:SILF)
Historical Stock Chart
From May 2023 to May 2024